Back
Adobe, Inc. 10K Form
Sell
44
ADBE
Adobe, Inc.
Last Price:
$300.09
Seasonality Move:
15.5%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2025-08-15 | 10K | ADBE/Adobe, Inc. Annual |
| 2025-07-15 | 10K | ADBE/Adobe, Inc. Annual |
| 2025-06-15 | 10K | ADBE/Adobe, Inc. Annual |
| 2025-05-15 | 10K | ADBE/Adobe, Inc. Annual |
| 2025-04-15 | 10K | ADBE/Adobe, Inc. Annual |
| 2025-03-15 | 10K | ADBE/Adobe, Inc. Annual |
Receive ADBE News And Ratings
See the #1 stock for the next 7 days that we like better than ADBE
ADBE Financial Statistics
Sales & Book Value
| Annual Sales: | $23.8B |
|---|---|
| Cash Flow: | $3.2B |
| Price / Cash Flow: | 13.17 |
| Annual Sales: | $28.14 |
| Price / Book: | 10.59 |
Profitability
| EPS (TTM): | 16.70550 |
|---|---|
| Net Income (TTM): | $7.1B |
| Gross Margin: | $21.1B |
| Return on Equity: | 57.46% |
| Return on Assets: | 24.33% |
Adobe, Inc. Earnings Forecast
Key Adobe, Inc. Financial Ratios
-
The Gross Profit Margin over the past 41 years for ADBE is 88.61%.
-
The Selling, General & Administrative Expenses for ADBE have been equal to 33.92% of Gross Profit Margin.
-
The Research & Development expenses have been 18.07% of Revenue.
-
The Interest Expense is 3.65% of Operating Income.
-
The Net Earning history of ADBE is 30.00% of Total Revenues.
-
Per Share Earnings over the last 41 years have been positive in 29 years.
Adobe, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | S&P500 |
|---|---|
| Industry: | Software |
| Sector: | Information Technology |
| Current Symbol: | ADBE |
| CUSIP: | 00724F |
| Website: | adobe.com |
Debt
| Debt-to-Equity Ratio: | 0.57 |
|---|---|
| Current Ratio: | 0.97 |
| Quick Ratio: | 0.9 |
Price-to-Earnings
| Trailing P/E Ratio: | 17.95 |
|---|---|
| Forward P/E Ratio: | 11.36 |
ADBE Technical Analysis vs Fundamental Analysis
Sell
44
Adobe, Inc. (ADBE)
is a Sell
Is Adobe, Inc. a Buy or a Sell?
-
Adobe, Inc. stock is rated a SellThe current Adobe, Inc. [ADBE] share price is $299.73. The Score for ADBE is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.